Tools & Calculators
Minimum Investment
TBA
TBA
TBA
TBA
TBA
NSE, BSE
TBA
TBA
TBA
TBA
TBA
TBA
TBA
TBA
Supreet Chemicals is a specialty chemical intermediates manufacturer, focusing on complex chemistries and multi-step processes. Its products are grouped into Aromatic Amines and Sulphonamides, Amino Phenols, and other specialties. In Fiscal 2025, it offered 135 products, with 74 involving up to five-step processes and 61 requiring six to fifteen steps. Serving 215 customers, including 27 global clients, its portfolio caters to industries such as textiles, pharmaceuticals, performance chemicals, and agrochemicals. With three facilities in Vapi, Gujarat, it operates 6,962 MTPA capacity, planning expansion to 12,985 MTPA.
Supreet Chemicals Ltd. filed its Draft Red Herring Prospectus (DRHP) with SEBI on September 5, 2025, to raise funds through an Initial Public Offer (IPO). The IPO is structured as a book-building issue with a total size of ₹499 crore, consisting entirely of a fresh issue of shares, without any offer-for-sale component. The company has proposed to list its equity shares on both NSE and BSE. IIFL Capital Services Ltd. is acting as the book-running lead manager, while MUFG Intime India Pvt. Ltd. has been appointed as the registrar. Key details such as IPO opening and closing dates, price band, and lot size are yet to be disclosed. Investors can refer to the Supreet Chemicals IPO DRHP for further details.
As per the DRHP, the equity shares carry a face value of ₹2 each, with the total issue size aggregating up to ₹499 crore. This will be a book-building IPO, and the company’s pre-issue shareholding stands at 6,35,19,000 equity shares. The promoters of Supreet Chemicals Ltd. are Harjindersingh Jaswant Singh Sarna, Narendrakaur H. Sarna, and Manjeetsingh Gurbirsingh Sarna. Their collective promoter holding before the issue is 81.26%, which will be diluted post-issue
| Category | Details |
| Issue Type | Book Built Issue IPO |
| Total Issue Size | ₹499 crore |
| Fresh Issue | ₹499 crore |
| Offer for Sale (OFS) | NA |
| IPO Dates | TBA |
| Price Bands | TBA |
| Lot Size | TBA |
| Face Value | ₹2 per share |
| Listing Exchange | BSE, NSE |
| Shareholding pre-issue | 6,35,19,000 shares |
| Shareholding post-issue | TBA |
| Application | Lots | Shares | Amount |
| Retail (Min) | TBA | TBA | TBA |
| Retail (Max) | TBA | TBA | TBA |
| S-HNI (Min) | TBA | TBA | TBA |
| S-HNI (Max) | TBA | TBA | TBA |
| B-HNI (Min) | TBA | TBA | TBA |
| Investor Category | Shares Offered |
| QIB Shares Offered | Not more than 50% of the Offer |
| Retail Shares Offered | Not less than 35% of the Offer |
| NII (HNI) Shares Offered | Not less than 15% of the Offer |
| KPI | Value |
| Earnings Per Share (EPS) | ₹8.17 |
| Price/Earnings (P/E) Ratio | TBD |
| Return on Net Worth (RoNW) | 24.51% |
| Net Asset Value (NAV) | ₹37.35 |
| Return on Equity (RoE) | 24.51% |
| Return on Capital Employed (RoCE) | 19.61% |
| EBITDA Margin | 21.63% |
| PAT Margin | 14.06% |
| Debt to Equity Ratio | 0.85 |
The Net Proceeds are intended to be utilised as per the details provided in the table below:
| Particulars | Amount (in ₹ million) |
| Financing the capital expenditure requirements of our Company towards Manufacturing Facility 4 (“Proposed Greenfield Project”) | 3100 |
| Repayment or prepayment, in full or in part, of all or a portion of certain outstanding borrowings availed by our Company | 650 |
| General corporate purposes* | [●] |
Note: *To be determined upon finalisation of the Offer Price and updated in the Prospectus prior to filing with the RoC
| Particulars | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 5,191.48 | 3,387.58 | 2,260.93 |
| Revenue | 3,625.47 | 2,397.56 | 3,127.41 |
| Profit After Tax | 519.18 | 255.94 | 563.41 |
| Reserves and Surplus | 2,245.09 | 1,737.75 | 1,494.57 |
| Total Borrowings | 2,007.03 | 808.94 | 46.60 |
| Total Liabilities | 2,819.35 | 1,522.79 | 639.32 |

Explore our comprehensive IPO pages to stay updated on the latest trends and insights.
Expertise in Complex Chemical Processes
Supreet Chemicals Limited possesses expertise in handling over 15 complex chemistries and up to 15 multi-step unit operations. This capability, built through years of operational experience, allows it to optimize raw materials, enhance yields, and increase cost competitiveness for a wide range of end-products and applications.
Extensive and Diversified Product Portfolio
The company has consistently expanded its commercialized product portfolio from 102 products in Fiscal 2023 to 135 in Fiscal 2025. This diversification, coupled with a robust pipeline of 107 development-stage products, limits dependence on any single product and mitigates risks associated with different industry business cycles.
Diversified End-Use Industry Exposure
Supreet’s products serve various end-use industries, including textiles, pharmaceuticals, performance chemicals, and personal care. This diversified exposure reduces reliance on any single sector, enhances resilience against sector-specific downturns, and ensures long-term stability for its business model.
Diversified and Long-Standing Customer Base
The company benefits from a well-diversified customer base, supplying to 215 customers in Fiscal 2025. It has developed long-standing relationships with key customers due to consistent product quality and reliable supply, which mitigates concentration risks and provides stability to its revenue profile.
Integrated Manufacturing and Capacity Expansion
Supreet operates three integrated manufacturing facilities in Vapi, Gujarat, with an aggregate capacity of 6,962 MTPA. Its track record of timely capacity additions and adoption of modern technology supports productivity and efficiency, with plans to further expand capacity to 12,985 MTPA.
Experienced Leadership and Management Team
The company is led by an experienced promoter and management team with extensive industry experience. This team’s depth and diversity enable Supreet to anticipate market trends, manage operations, maintain customer relationships, and respond effectively to changes in the market.
Supreet Chemicals Limited is a leading manufacturer of specialty chemical intermediates, renowned for its expertise in handling complex chemistries and multi-step production processes. The company’s advanced capabilities enable it to serve a diverse range of end-use industries, including textiles, pharmaceuticals, performance chemicals, personal care, and agro-chemicals.
Operational and Manufacturing Strength
Supreet Chemicals has consistently expanded and complexified its product offerings. The number of products involving six to 15 multi-step processes grew from 41 in Fiscal 2023 to 61 in Fiscal 2025.
Customer Base and Business Model
The company has built strong, established relationships with a large customer base, serving 215 customers in Fiscal 2025 across India and 14 global countries.
The Indian specialty chemicals market was valued at around USD 63–65 billion in 2024 and is projected to reach nearly USD 90–96 billion by 2033–34, growing at a CAGR of 3.8–4.5%. Some sub-segments are expected to grow much faster, at 10–12% annually, due to increasing domestic and export demand. Specialty chemicals account for about one-fourth of India’s total chemicals and petrochemicals industry, highlighting their strategic importance.
Growth Drivers
Outlook for Supreet Chemicals’ Product Segments
Key Figures
Peer Group Comparison
| Name of the Company | Face Value (₹) | P/E | EPS (Basic) | EPS (Diluted) | RoNW (%) | NAV (₹ per share) |
| Supreet Limited | 2 | [•] | 8.17 | 8.17 | 24.51% | 37.35 |
| Peer Group | ||||||
| Deepak Nitrite Ltd | 2 | 35.40 | 51.12 | 51.12 | 13.69% | 395.06 |
| Aarti Industries Ltd | 5 | 41.33 | 9.13 | 9.12 | 6.07% | 154.62 |
| Atul Ltd | 10 | 38.40 | 164.37 | 164.37 | 9.03% | 1,901.57 |
| Balaji Amines Ltd | 2 | 30.39 | 48.62 | 48.62 | 8.83% | 569.46 |
| Alkyl Amines Chemicals Ltd | 2 | 55.68 | 36.40 | 36.35 | 13.94% | 274.31 |
| Neogen Chemicals Ltd | 10 | 108.95 | 13.20 | 13.20 | 4.49% | 299.24 |
| Rossari Biotech Ltd | 2 | 25.06 | 24.66 | 24.65 | 12.21% | 214.13 |
Portfolio Diversification and High-Margin Focus
The company’s strategy is to diversify its product portfolio by developing new, high-margin specialty chemical intermediates. This involves continuous R&D, adopting cleaner technologies, and performing complex, multi-step operations for niche products to improve its overall margin profile and profitability.
Enhancing Technical Competencies
Supreet aims to enhance its competencies by developing more complex processes, including those with up to 20 multi-step operations. This focus on advanced chemistries and processes is intended to optimize raw materials, improve yields, and increase its cost competitiveness in the market.
Increasing Customer Wallet Share
The strategy involves deepening relationships with key customers to increase wallet share. Supreet plans to achieve this by offering more specialized and customized products, expanding into new end-use markets, and leveraging its contract manufacturing model to optimize capacity utilization
Follow these simple steps to apply for an IPO through HDFC SKY. Secure your investments and explore new opportunities with ease by accessing the IPOs available on the platform.
1Login to your HDFC SKY Account
2Select Issue
3Enter Number of Lots and your Price.
4Enter UPI ID
5Complete Transaction on Your UPI App
You can apply via HDFCSky or other brokers using UPI-based ASBA (Application Supported by Blocked Amount).
The IPO size is ₹499 crore, entirely through fresh issue of equity shares without any offer for sale.
The company’s equity shares are proposed to be listed on both NSE and BSE after the IPO.
IIFL Capital Services Ltd. is the book running lead manager, and MUFG Intime India Pvt. Ltd. is registrar.
Proceeds will fund a new greenfield manufacturing facility, repay borrowings, and support general corporate purposes.
No, the IPO price band and lot size details are yet to be officially announced.